FDA Approves ARROW UltraQuik Needles

The ARROW UltraQuik peripheral nerve block needles by Teleflex International received 510(k) clearance from the FDA, according to Daily Finance.

Advertisement

The needles feature five grooved rings at the tip for better clinician identification with an ultrasound during single-inject peripheral nerve blocks.

More Articles on Anesthesia:
Somnia Anesthesia Releases New Case Studies on Anesthesia Leadership
ASA Presses for Anesthesiologist Meaningful Use Stage 3 Exemption
Noridian Adjusts Anesthesia Coverage Policy After Unintended Denials

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Artificial Intelligence

Advertisement

Comments are closed.